SURMOUNT Study Results: Tirzepatide Weight Loss Data
SURMOUNT-2 found tirzepatide 15mg cut body weight 15.7% at 72 weeks in adults with diabetes and obesity, versus 3.3% on placebo. See full SURMOUNT program results.
Tirzepatide: Dosing, Weight Loss Results & FDA Approval
Tirzepatide (Mounjaro, Zepbound) produced 20.9% mean weight loss at 72 weeks in SURMOUNT-1. See dosing schedule, titration steps, and approval details.
Wegovy vs Saxenda: Which GLP-1 Weight Loss Injection Works Better?
A clinical comparison of semaglutide (Wegovy) and liraglutide (Saxenda) for weight loss, including head-to-head trial data, dosing schedules, side-effect profiles, and cost. Reviewed by a board-certified endocrinologist.
Wegovy vs Zepbound: Which Weight-Loss Drug Works Better?
A clinical comparison of semaglutide (Wegovy) and tirzepatide (Zepbound) covering mechanism, weight-loss outcomes, side effects, dosing, cost, and how to choose between them.
Who Should Not Take GLP-1 Medications (Wegovy, Ozempic, Zepbound)?
A guide covering every contraindication, caution, and drug interaction for GLP-1 receptor agonists, including semaglutide and tirzepatide, with cited clinical evidence.
Zepbound: What It Is, How It Works, and How It Compares to Wegovy, Ozempic, and Saxenda
A deep dive into Zepbound (tirzepatide) for weight loss, including mechanism, dosing, side effects, and head-to-head data against semaglutide and liraglutide.
Zepbound Vials vs. Pen - Are They Equally Effective?
Zepbound vials and pens contain the same tirzepatide dose and concentration, giving identical weight loss and glycemic results when dosed correctly.
Are Zepbound® Vials Covered by Insurance the Same Way as Pens?
A detailed clinical and insurance guide comparing Zepbound vial vs. Pen coverage, prior authorization requirements, cost differences, and what to do when your plan denies tirzepatide.
Can Natural Foods Ever Replace Prescription Medications Like Ozempic®?
A comparison of dietary GLP-1 strategies versus semaglutide and other GLP-1 receptor agonists. Learn what the clinical evidence says about food-first approaches, their real limits, and when a prescription is medically warranted.
Does Blue Cross Blue Shield of Michigan Cover Tirzepatide (Mounjaro)?
A detailed guide to BCBSM tirzepatide coverage, prior authorization requirements, step therapy rules, and how to get Mounjaro or Zepbound approved in Michigan in 2025.
Does Blue Cross Blue Shield of North Carolina Cover Ozempic?
A detailed guide to BCBSNC Ozempic coverage, prior authorization requirements, formulary tiers, and what to do if your claim is denied, with clinical context and cost-saving options.
Does Oral Tirzepatide Work as Well as Injections?
A comparison of oral vs. Injectable tirzepatide covering bioavailability, clinical trial data, weight loss outcomes, dosing, and who each form suits best.
Is Microdosing Tirzepatide Safe? Microdosing vs. Standard Titration Explained
A clinical breakdown of microdosing tirzepatide versus standard titration: what the evidence shows about safety, tolerability, and weight-loss outcomes for GLP-1/GIP therapy.
What Is the Most Common Mounjaro Dosage and Titration Schedule?
A guide to Mounjaro (tirzepatide) starting doses, titration steps, maintenance doses, and how programs like Calibrate approach dose escalation for weight loss and type 2 diabetes.
Who Can Take Mounjaro (Tirzepatide)? Eligibility, Contraindications, and How to Start
Find out exactly who qualifies for Mounjaro (tirzepatide) based on FDA labeling, BMI cutoffs, comorbidity criteria, and absolute contraindications. Written by the HealthRX.com medical team.
Why Can Microdosing Ozempic Be Risky?
Microdosing Ozempic (semaglutide) may seem like a cautious approach, but sub-therapeutic dosing carries real clinical risks including inadequate glycemic control, rebound weight gain, and GLP-1 receptor desensitization. Learn what the evidence says and when dose titration actually matters.
Does Aetna Cover Semaglutide (Wegovy)?
A detailed guide to Aetna's semaglutide (Wegovy) coverage rules, prior authorization requirements, out-of-pocket costs, and what to do if you are denied.
Does Affinity Health Plan Cover Ozempic?
A detailed, clinically grounded guide to Affinity Health Plan coverage for Ozempic (semaglutide), including prior authorization steps, alternatives, and appeal strategies.
Does Amerigroup Cover Ozempic?
Find out whether Amerigroup Medicaid and Medicare Advantage plans cover Ozempic (semaglutide), what prior authorization steps are required, what alternatives may be covered, and how to appeal a denial.
Does Amerigroup Cover Tirzepatide (Mounjaro)?
A detailed guide to Amerigroup coverage of tirzepatide (Mounjaro) for type 2 diabetes and weight loss, including prior authorization steps, formulary tiers, and how to appeal a denial.
Ozempic Effect on AST: What the Clinical Evidence Shows
Semaglutide 0.5 to 2.0 mg (Ozempic) typically lowers AST in people with type 2 diabetes and fatty liver disease. Learn the magnitude, timing, mechanism, and when to check your labs.
Zepbound Effect on CMP (Comprehensive Metabolic Panel): What the Labs Actually Show
Tirzepatide (Zepbound) changes kidney function markers, liver enzymes, glucose, and electrolytes on a CMP. Here is what RCT data, FDA labeling, and post-market reports show about direction, magnitude, timing, and monitoring intervals.
Mounjaro and Bupropion Interaction: What Patients and Prescribers Need to Know
A guide to the tirzepatide-bupropion drug interaction: mechanisms, seizure risk, CYP2D6 inhibition, monitoring, and dose-adjustment guidance with primary citations.
Mounjaro and Finasteride Interaction: What Patients and Clinicians Need to Know
A guide to the tirzepatide, finasteride drug interaction: mechanism, pharmacokinetics, androgen pathway overlap, monitoring parameters, and practical prescribing guidance.
Mounjaro and Tadalafil Interaction: What Patients and Clinicians Need to Know
A guide to the tirzepatide, tadalafil drug interaction, covering mechanism, hypotension risk, monitoring parameters, dose considerations, and patient counseling.
Mounjaro and Trazodone Interaction: What Patients and Prescribers Need to Know
A clinical review of the tirzepatide, trazodone drug interaction covering pharmacokinetics, pharmacodynamic overlap, monitoring parameters, and patient counseling guidance.
Ozempic and Metformin Interaction: What Patients and Clinicians Need to Know
A clinical guide to the Ozempic (semaglutide) and metformin combination: mechanism, hypoglycemia risk, renal monitoring, dosing considerations, and patient counseling points, drawn from FDA labeling and published trial data.
Ozempic and Simvastatin Interaction: What Patients and Clinicians Need to Know
A guide to the semaglutide, simvastatin drug interaction: mechanism, severity, monitoring parameters, dose adjustments, and patient counseling points.
Ozempic and SSRIs (Sertraline, Escitalopram): Interaction Guide
Can you take Ozempic with SSRIs like sertraline or escitalopram? A breakdown of the pharmacokinetic and pharmacodynamic interactions, serotonin syndrome risk, monitoring protocols, and dose-adjustment guidance.
Ozempic and Trazodone Interaction: What Patients and Prescribers Need to Know
A clinician-level review of the Ozempic (semaglutide) and trazodone drug interaction, covering pharmacokinetic mechanisms, sedation risk, blood sugar effects, QTc considerations, monitoring parameters, and practical dose-adjustment guidance.
Mounjaro Alcohol Interaction Profile: What You Need to Know Before You Drink
A comprehensive clinical guide to the Mounjaro (tirzepatide) and alcohol interaction, covering hypoglycemia risk, GI effects, pancreatitis, and safe drinking guidelines reviewed by HealthRX.com physicians.
Mounjaro and Anesthesia: Perioperative Risks, Fasting Rules, and What to Tell Your Surgeon
Tirzepatide (Mounjaro) slows gastric emptying, raising aspiration risk under anesthesia. Learn the evidence-based fasting protocols, when to hold your dose, and how to talk to your anesthesiologist before any procedure.
Mounjaro and Imaging Contrast Dye: What You Need to Know Before Your Scan
A guide to the tirzepatide (Mounjaro) contrast dye interaction: why gastroparesis-like slowing raises aspiration risk, what the ACR recommends, and exactly how to time your scan safely.
Mounjaro Nicotine Interaction Profile: What Tirzepatide Users Need to Know
A clinical review of the Mounjaro (tirzepatide) and nicotine interaction, covering pharmacokinetics, GI risk, cardiovascular effects, and practical guidance for patients who smoke, vape, or use nicotine replacement therapy.
Ozempic and Anesthesia: Perioperative Risks, Aspiration Danger, and What to Tell Your Surgeon
A guide to the Ozempic anesthesia interaction: gastroparesis risk, aspiration under general anesthesia, fasting protocol changes, and ASA/ASGE recommendations for perioperative semaglutide management.
Ozempic and Nicotine: What You Need to Know About This Interaction
A guide to the Ozempic nicotine interaction profile, covering pharmacokinetics, cardiovascular risks, GI effects, weight changes, and what to tell your prescriber.
Wegovy and Caffeine: The Full Interaction Profile
Does caffeine interact with Wegovy (semaglutide 2.4 mg)? A guide covering pharmacokinetics, gastric-emptying effects, heart rate, anxiety, and practical dosing advice.
Wegovy and Benzodiazepines Interaction: What Patients and Prescribers Need to Know
A clinical review of the pharmacokinetic and pharmacodynamic interactions between semaglutide 2.4 mg (Wegovy) and benzodiazepines, including monitoring guidance, dose considerations, and patient counseling points.
Wegovy and Hormonal Contraceptives: What the Interaction Data Actually Show
A guide to the interaction between semaglutide 2.4 mg (Wegovy) and hormonal contraceptives, covering mechanism, absorption risk, monitoring, and patient counseling for women on combined therapy.
Wegovy and Bupropion Interaction: What Patients and Prescribers Need to Know
A guide to the semaglutide 2.4 mg and bupropion drug interaction, covering mechanism, seizure risk, monitoring protocols, and dose-adjustment guidance.
Wegovy and Clopidogrel Interaction: What Patients and Prescribers Need to Know
A guide to the pharmacokinetic and pharmacodynamic interaction between semaglutide 2.4 mg (Wegovy) and clopidogrel, including mechanism, severity, monitoring parameters, and patient counseling.
Wegovy and Gabapentin Interaction: What Patients and Prescribers Need to Know
A clinical deep-dive into the semaglutide 2.4 mg and gabapentin drug interaction, covering pharmacokinetic mechanisms, CNS sedation overlap, renal considerations, monitoring parameters, and patient counseling points.
Wegovy and Progesterone HRT Interaction: What Patients and Clinicians Need to Know
A review of the pharmacokinetic and pharmacodynamic considerations when semaglutide 2.4 mg (Wegovy) is used alongside progesterone hormone therapy, including mechanism, evidence gaps, monitoring points, and questions to raise with a prescriber.
Wegovy and Pregabalin Interaction: What Patients and Prescribers Need to Know
What prescribing information and the actual studies establish about injectable Wegovy with pregabalin, absorption timing, weight response and tolerability.
Wegovy and SNRIs (Venlafaxine, Duloxetine): Drug Interaction Guide
A clinician-level review of combining semaglutide 2.4 mg (Wegovy) with SNRIs such as venlafaxine and duloxetine. Covers pharmacokinetic and pharmacodynamic mechanisms, serotonin syndrome risk, blood pressure monitoring, and dose-adjustment guidance.
Wegovy and Testosterone Interaction: What Patients and Clinicians Need to Know
A guide to the semaglutide 2.4 mg and testosterone drug interaction, covering mechanism, monitoring, dose adjustment, and patient counseling with primary-source citations.
Zepbound and Apixaban Interaction: What Patients and Prescribers Need to Know
A clinical-depth review of the tirzepatide, apixaban drug interaction, covering pharmacokinetic mechanisms, bleeding risk, INR monitoring, and dose-adjustment guidance for patients on Zepbound and apixaban.
Zepbound and Gabapentin Interaction: What Patients and Clinicians Need to Know
A clinical review of the tirzepatide-gabapentin drug interaction covering pharmacokinetics, pharmacodynamics, CNS and renal risk, monitoring parameters, and dose-adjustment guidance with primary-source citations.
Zepbound and Tadalafil Interaction: What Patients and Clinicians Need to Know
A clinical deep-dive into the tirzepatide-tadalafil drug interaction: mechanism, hypotension risk, monitoring parameters, dose guidance, and patient counseling, prepared by the HealthRX.com Editorial Team.
Traveling With Mounjaro (Tirzepatide): A Complete Guide to Staying on Track
Everything you need to know about traveling while on Mounjaro (tirzepatide): storage, injection timing, airport security, time-zone dosing shifts, and what to pack.
Ozempic and Alcohol: What You Need to Know While on This Drug
Drinking alcohol while taking Ozempic (semaglutide) carries real risks including hypoglycemia, pancreatitis flares, and unpredictable nausea. Here is what the clinical evidence and patient data say about combining the two.
Ozempic and Exercise: How to Work Out Safely and Effectively on Semaglutide
Everything you need to know about exercising on Ozempic (semaglutide 0.5 to 2.0 mg): timing workouts around injections, managing muscle loss, fueling sessions, and the clinical evidence behind combining GLP-1 therapy with physical activity.
Ozempic Life Events That Affect Dosing: A Clinical Guide
Surgery, illness, pregnancy, travel, and other life events can all shift how semaglutide works in your body. Learn exactly which situations require a dose hold, adjustment, or urgent call to your prescriber.
Ozempic Nutrition for Best Outcomes: What to Eat, Avoid, and Track
A guide to eating on semaglutide (Ozempic 0.5 to 2.0 mg): optimal food choices, meal timing, protein targets, GI management, and real-world evidence to maximize weight and glycemic results.
Ozempic, Relationships, and Intimacy: What the Evidence Actually Shows
Semaglutide changes appetite, body image, mood, and libido in ways that ripple through partnerships. Here is what patient-reported outcomes, clinical trial data, and practicing clinicians say about managing those changes.
Rybelsus and Exercise: How to Work Out Safely on Oral Semaglutide
Learn how Rybelsus (oral semaglutide) affects exercise capacity, blood sugar, and recovery. Evidence-based guidance on workout timing, hydration, and hypoglycemia risk for people with type 2 diabetes.
Rybelsus and Relationships: How Oral Semaglutide Affects Intimacy and Daily Life
A clinical deep-dive into how Rybelsus (oral semaglutide) affects intimate relationships, sexual health, body image, and daily routines, with real-world evidence, patient-reported outcomes, and physician guidance.
Wegovy Life Events That Affect Dosing: A Clinical Guide
Surgery, pregnancy, illness, travel, and other life events can all disrupt your Wegovy dosing schedule. Learn exactly what to do in each scenario, backed by FDA labeling, clinical trial data, and endocrinologist guidance.
Zepbound and Alcohol: What You Actually Need to Know Before Drinking on Tirzepatide
Drinking alcohol while taking Zepbound (tirzepatide)? Learn how alcohol interacts with GLP-1/GIP receptor agonists, what the clinical evidence shows, and practical rules for staying safe.
Zepbound Nutrition for Best Outcomes: What to Eat, What to Avoid, and How to Get the Most from Tirzepatide
A guide to optimizing nutrition on Zepbound (tirzepatide): meal composition, protein targets, hydration, supplement needs, and practical daily-life strategies, with clear flags on what is established versus extrapolated from general weight-loss research.